iCas9 HA-T2A-antiCD19scFv-CD28-CD3z−BEAM
Item Information | ||
---|---|---|
Catalog # | Size/Concentration | Price |
Specification | |
---|---|
ProductOrder | I |
Shipping Information | This product will ship in a box containing dry ice at a temperature of -80°C. Learn More |
Item Information | ||
---|---|---|
Catalog # | Size/Concentration | Price |
Specification | |
---|---|
ProductOrder | I |
Shipping Information | This product will ship in a box containing dry ice at a temperature of -80°C. Learn More |
Description | The inducible caspase-9-CD19 CAR construct consists of FKBP12 gene with mutation F36 to V coding two 12 kDa FK506 binding proteins with HA tag at the end fused to truncated Caspase9 (135-416; lacking pro-domain), followed by T2A peptide and then CD19scFv-CD28- CD3zeta without signaling peptide and with BEAM. This construct can be used as a negative control for PM-CAR1006-1M (it expressed same length as icasp-CD19 without tags but is nonfunctional protein). In the presence of dimerization agent, AP20187 or AP1903, caspase-9 is activated inducing cell killing. Introduction of inducible caspase-9 can be used for increasing safety of CAR-T cells in the presence of dimerization agent |